Article Details

Jazz Pharmaceuticals Submits Biologics License Application for Zanidatamab to Treat ...

Retrieved on: 2024-04-03 19:30:41

Tags for this article:

Click the tags to see associated articles and topics

Jazz Pharmaceuticals Submits Biologics License Application for Zanidatamab to Treat .... View article details on hiswai:

Excerpt

Bispecific Antibodies Emerge in the Treatment of Multiple Myeloma ... Unlike conventional monoclonal antibodies, BsAbs possess dual binding domains that ...

Article found on: www.pharmacytimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up